IEQ Capital’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Sell |
12,532
-5,097
| -29% | -$47.3K | ﹤0.01% | 1697 |
|
|
2025
Q1 | $129K | Hold |
17,629
| – | – | ﹤0.01% | 1443 |
|
|
2024
Q4 | $151K | Hold |
17,629
| – | – | ﹤0.01% | 1239 |
|
|
2024
Q3 | $153K | Hold |
17,629
| – | – | ﹤0.01% | 1080 |
|
|
2024
Q2 | $121K | Sell |
17,629
-12,500
| -41% | -$85.5K | ﹤0.01% | 945 |
|
|
2024
Q1 | $274K | Hold |
30,129
| – | – | ﹤0.01% | 792 |
|
|
2023
Q4 | $134K | Sell |
30,129
-54,400
| -64% | -$243K | ﹤0.01% | 870 |
|
|
2023
Q3 | $265K | Hold |
84,529
| – | – | 0.01% | 760 |
|
|
2023
Q2 | $436K | Hold |
84,529
| – | – | 0.01% | 578 |
|
|
2023
Q1 | $445K | Sell |
84,529
-55,000
| -39% | -$290K | 0.01% | 610 |
|
|
2022
Q4 | $392K | Sell |
139,529
-144,404
| -51% | -$406K | 0.01% | 563 |
|
|
2022
Q3 | $1.18M | Hold |
283,933
| – | – | 0.03% | 328 |
|
|
2022
Q2 | $1.14M | Sell |
283,933
-124,000
| -30% | -$498K | 0.03% | 288 |
|
|
2022
Q1 | $2.02M | Hold |
407,933
| – | – | 0.05% | 206 |
|
|
2021
Q4 | $2.84M | Sell |
407,933
-221,049
| -35% | -$1.54M | 0.07% | 155 |
|
|
2021
Q3 | $6.29M | Buy |
628,982
+49
| +0% | +$490 | 0.17% | 79 |
|
|
2021
Q2 | $8.92M | Hold |
628,933
| – | – | 0.26% | 58 |
|
|
2021
Q1 | $10.3M | Hold |
628,933
| – | – | 0.43% | 42 |
|
|
2020
Q4 | $13M | Sell |
628,933
-50,300
| -7% | -$1.04M | 0.58% | 40 |
|
|
2020
Q3 | $5.17M | Hold |
679,233
| – | – | 0.28% | 60 |
|
|
2020
Q2 | $5.66M | Buy |
679,233
+423,188
| +165% | +$3.53M | 0.37% | 47 |
|
|
2020
Q1 | $1.27M | Hold |
256,045
| – | – | 0.1% | 122 |
|
|
2019
Q4 | $1.01M | Buy |
+256,045
| New | +$1.01M | 0.09% | 155 |
|